DJ Abbott Laboratories Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slid 2.15% to $87.54 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.41% to 7,200.75 and Dow Jones Industrial Average falling 1.13% to 48,941.90.
This was the stock's fourth consecutive day of losses.
Abbott Laboratories closed 37.05% below its 52-week high of $139.06, which the company reached on June 24th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.32% to $224.20, Pfizer Inc. $(PFE)$ fell 0.11% to $26.30, and Merck & Co. Inc. $(MRK)$ rose 0.85% to $113.11.
Trading volume (14.5 M) eclipsed its 50-day average volume of 12.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 04, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments